Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08NCO
|
|||
| Former ID |
DNC001494
|
|||
| Drug Name |
Vanadate
|
|||
| Synonyms |
Ammonium metavanadate; 7803-55-6; Ammonium vanadate(V); UNII-FL85PX638G; FL85PX638G; Ammonium metavanadate, ACS reagent; Ammoniummetavanadate; Ammonium metavanadate, 99.5%, for analysis; Ammonium metavanadate, 99.996%, (trace metal basis); Ammonium meta-Vanadate; Vanadate (VO31-), ammonium (1:1); AC1LANGP; ammonium vanadiumoylolate; H4NO3V; EC 232-261-3; azanium oxido(dioxo)vanadium; KS-00000WUM; UNTBPXHCXVWYOI-UHFFFAOYSA-O; MolPort-044-723-987; MolPort-003-925-733; MFCD00011430; AKOS030228605; AMMONIUM VANADATE (META), NH4VO3
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Psoriatic arthritis [ICD-11: FA21; ICD-9: 696] | Phase 3 | [1] | |
| Rheumatoid arthritis [ICD-11: FA20] | Phase 3 | [1] | ||
| Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Application submitted | [1] | ||
| Structure |
 |
Download2D MOL |
||
| Formula |
H4NO3V
|
|||
| Canonical SMILES |
[NH4+].[O-][V](=O)=O
|
|||
| InChI |
1S/H3N.3O.V/h1H3;;;;/q;;;-1;/p+1
|
|||
| InChIKey |
UNTBPXHCXVWYOI-UHFFFAOYSA-O
|
|||
| CAS Number |
CAS 7803-55-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sarcoplasmic/endoplasmic reticulum calcium ATPase (ATP2A) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J Biol Chem. 2001 Apr 6;276(14):10782-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.